FDA Inspection 999141 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on January 25, 2017 in Independence, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 25, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Independence, MO (United States)